0000000000529061

AUTHOR

R Bartoletti

showing 5 related works from this author

Prognostic factors and risk groups in T1G3 patients initially treated with BCG: Results of a multicenter retrospective series in 1743 patients

2013

Introduction and Objectives: The impact of prognostic factors in T1G3 patients (pts) is critical for proper treatment decision making, however most available data are from small series of pts. The aim of the current study is to assess prognostic factors in a large group of pts who received BCG as initial treatment of T1G3 tumours and identify a subgroup of high risk pts who should be considered for early cystectomy. Patients and Methods: Individual pt data were collected for 1743 ptsfrom 20 centers who received induction or maintenance BCG between 1990 and 2008. Using Cox regression analysis, the prognostic importance of the following variables were assessed for time to recurrence, progress…

Bladder cancer T1HGSettore MED/24 - Urologia
researchProduct

THE IMPACT OF RE-TUR ON CLINICAL OUTCOMES IN A LARGE COHORT OF T1G3 PATIENTS TREATED WITH BCG.

2014

Scopo del lavoro Re-TUR is strongly advocated for T1G3, because of the high incidence residual disease and mainly the risk of substaging. Its real clinical value remains to be determined and the clinical factors that may influence the decision. Some authors suggest that when muscle is present in the specimen, re-TUR may be avoided. To evaluate if the presence of muscle or not at the first TUR in T1G3 bladder cancer makes a difference in recurrence, progression and cancer specific survival after re-TUR. Materiali e metodi In a large retrospective cohort of 2530 primary T1G3 initially treated with BCG, 953 (37.7%) had a re-TUR. According to the presence or not of muscle in the specimen of pri…

bladder cancer prognosis re-TUR BCGSettore MED/24 - Urologia
researchProduct

Telehealth in Urology: A Systematic Review of the Literature. How Much Can Telemedicine Be Useful During and After the COVID-19 Pandemic?

2020

Context Coronavirus disease 2019 (COVID-19) pandemic has caused increased interest in the application of telehealth to provide care without exposing patients and physicians to the risk of contagion. The urological literature on the topic is sparse. Objective To perform a systematic review of the literature and evaluate all the available studies on urological applications of telehealth. Evidence acquisition After registration on PROSPERO, we searched PubMed and Scopus databases to collect any kind of studies evaluating any telehealth interventions in any urological conditions. The National Toxicology Program/Office of Health Assessment and Translation Risk of Bias Rating Tool for Human and A…

Coronavirus; COVID-19; E-health; Severe acute respiratory syndrome coronavirus 2; Telehealth; Telemedicinemedicine.medical_specialtyTelemedicineTelemedicine.UrologyUrinary systemCoronaviru030232 urology & nephrologyPsychological interventionUrinary incontinenceContext (language use)TelehealthArticleCOVID-19; Coronavirus; E-health; Severe acute respiratory syndrome coronavirus 2; Telehealth; Telemedicinelaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled triallawHealth caremedicineSevere acute respiratory syndrome coronavirus 2Intensive care medicineE-healthCOVID-19; Coronavirus; E-health; Severe acute respiratory syndrome coronavirus 2; Telehealth; Telemedicine.business.industryCOVID-19COVID-19 Coronavirus E-health Severe acute respiratory syndrome coronavirus 2 Telehealth Telemedicine.TelemedicineCoronavirusTelehealth030220 oncology & carcinogenesismedicine.symptombusinessCoronavirus COVID-19 E-health Severe acute respiratory syndrome coronavirus 2 Telehealth TelemedicineEuropean Urology
researchProduct

INCIDENC, LIFESTYLE AND SUBJECTIVE SYMPTOMS IN PATIENTS WITH PROSTATITIS: RESULTS OF THE ITALIAN OBSERVATIONAL STUDY

2007

PROSTATITISSettore MED/24 - Urologia
researchProduct

THE IMPACT OF DIFFERENT BCG STRAINS ON OUTCOME IN A LARGE COHORT OF T1G3 PATIENTS TREATED WITH BCG

2015

bladder cancer BCGSettore MED/24 - Urologia
researchProduct